 Akcea Therapeutics Inc NASDAQ:AKCA major shareholder Ionis Pharmaceuticals Inc acquired 21,237,715 shares of the stock in a transaction that occurred on Saturday, October 10th. The shares were bought at an average price of 18.15 per share, with a total value of 385,464,527.25. The purchase was disclosed in a legal filing with the Securities Exchange ... 